 |
|
|
|
|
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Pahnke J. on PAPER: Fitz NF. et al., 2012, This study by Fitz et al. nicely shows how different ApoE phenotypes may affect amyloid and Aβ... 28 Sep 2012.
|
|
|
 |
|
|
Pahnke J. on NEWS: Bapineuzumab Phase 3: Target Engagement, But No Benefit, Yet another devastating result. It seems that there is an important piece in the puzzle missing.... 17 Sep 2012.
|
|
|
|
|
|
Pahnke J. on NEWS: Brain Drain—“Glymphatic” Pathway Clears Aβ, Requires Water Channel, Nice work, that now adds “moving” data to the description by Roy Weller in the 1980s, who found... 23 Aug 2012.
|
|
|
|
|
|
Pahnke J. on NEWS: Protective APP Mutation Found—Supports Amyloid Hypothesis, This is a nice finding by Jonsson et al., and adds more evidence to the idea published in 2009... 18 Jul 2012.
|
|
|
|
|
|
Pahnke J. on NEWS: Paper Alert: In Vivo Human Data Shows Reduced Aβ Clearance in AD, Congratulations!
Very nice study showing the effects of reduced Aβ
clearance in AD... 14 Dec 2010.
|
|
|
|
|
|
Pahnke J. on NEWS: Prion Protein Keeps β-secretase in Check, The paper by Parkin et al. is of extreme interest to the community. Since the physiological... 3 Jul 2007.
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
